From Paris to Montreal: disease regression is common during long term follow-up of paediatric Crohn’s disease

References

• Shivashankar R, Tremaine WJ, Harmsen WS, et al. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol. 2017;15:857–863.
   PubMed Web of Science ®Google Scholar
• Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, et al. Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis. 2013;19:1218–1223.
   PubMed Web of Science ®Google Scholar
• Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:2–15.
   PubMed Web of Science ®Google Scholar
• Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525–531.
   PubMed Web of Science ®Google Scholar
• Ashton JJ, Cullen M, Afzal NA, et al. Is the incidence of paediatric inflammatory bowel disease still increasing? Arch Dis Child. 2018;103:1093–1094.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112:1120–1134.
   PubMed Web of Science ®Google Scholar
• Henderson P, Wilson DC. The rising incidence of paediatric-onset inflammatory bowel disease. Arch Dis Child. 2012;97:585–586.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581–589.
   PubMed Web of Science ®Google Scholar
• de Bie CI, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;19:378–385.
   PubMed Web of Science ®Google Scholar
• Pigneur B, Seksik P, Viola S, et al. Natural history of Crohn’s disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis. 2010;16:953–961.
   PubMed Web of Science ®Google Scholar
• Levine A. Pediatric inflammatory bowel disease: is it different? Dig Dis. 2009;27:212–214.
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114–1122.
   PubMed Web of Science ®Google Scholar
• Urlep D, Trop TK, Blagus R, et al. Incidence and phenotypic characteristics of pediatric IBD in northeastern Slovenia, 2002-2010. J Pediatr Gastroenterol Nutr. 2014;58:325–332.
   PubMed Web of Science ®Google Scholar
• Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn’s disease: a population-based cohort study. Gastroenterology. 2008;135:1106–1113.
   PubMed Web of Science ®Google Scholar
• Fumery M, Pariente B, Sarter H, et al. Long-term outcome of pediatric-onset Crohn’s disease: a population-based cohort study. Dig Liver Dis. 2019;51:496–502.
   PubMedGoogle Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875–880.
   PubMed Web of Science ®Google Scholar
• Hope B, Shahdadpuri R, Dunne C, et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child. 2012;97:590–594.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Krasilnikoff PA, et al. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol. 1997;32:139–147.
   PubMed Web of Science ®Google Scholar
• Malmborg P, Grahnquist L, Idestrom M, et al. Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County. Inflamm Bowel Dis. 2015;21:1098–1108.
   PubMed Web of Science ®Google Scholar
• Larsen MD, Qvist N, Nielsen J, et al. Use of anti-TNFalpha agents and time to first-time surgery in paediatric patients with ulcerative colitis and Crohn’s disease. ECCOJC. 2016;10:650–656.
   Web of Science ®Google Scholar
• Kim HJ, Oh SH, Kim DY, et al. Clinical characteristics and long-term outcomes of paediatric Crohn’s disease: a single-centre experience. ECCOJC. 2017;11:157–164.
   Web of Science ®Google Scholar
• Rinawi F, Assa A, Hartman C, et al. Evolution of disease phenotype in pediatric-onset Crohn’s disease after more than 10 years follow up-cohort study. Dig Liver Dis. 2016;48:1444–1450.
   PubMedGoogle Scholar
• Kugathasan S, Denson LA, Walters TD, et al. Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study. Lancet. 2017;389:1710–1718.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Oussalah A, Williet N, et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn’s disease. Gut. 2011;60:930–936.
   PubMed Web of Science ®Google Scholar
• Safroneeva E, Vavricka SR, Fournier N, et al.; the Swiss IBD Cohort Study Group. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn’s disease. Aliment Pharmacol Ther. 2015;42:977–989.
   PubMed Web of Science ®Google Scholar
• Jeuring SF, van den Heuvel TR, Liu LY, et al. Improvements in the long-term outcome of Crohn’s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL Cohort. Am J Gastroenterol. 2017;112:325–336.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Guttmann A, To T, et al. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis. 2011;17:2153–2161.
   PubMed Web of Science ®Google Scholar
• Leonor R, Jacobson K, Pinsk V, et al. Surgical intervention in children with Crohn’s disease. Int J Colorectal Dis. 2007;22:1037–1041.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Mack DR, Nguyen GC, et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–813 e7. quiz e14–e15.
   PubMed Web of Science ®Google Scholar
• Blackburn SC, Wiskin AE, Barnes C, et al. Surgery for children with Crohn’s disease: indications, complications and outcome. Arch Dis Child. 2014;99:420–426.
   PubMed Web of Science ®Google Scholar
• Aloi M, Viola F, D’Arcangelo G, et al. Disease course and efficacy of medical therapy in stricturing paediatric Crohn’s disease. Dig Liver Dis. 2013;45:464–468.
   PubMedGoogle Scholar